A G Unnikrishnan

778 total citations
27 papers, 321 citations indexed

About

A G Unnikrishnan is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, A G Unnikrishnan has authored 27 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 7 papers in Surgery. Recurrent topics in A G Unnikrishnan's work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (7 papers) and Diabetes and associated disorders (6 papers). A G Unnikrishnan is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes Treatment and Management (7 papers) and Diabetes and associated disorders (6 papers). A G Unnikrishnan collaborates with scholars based in India, Sweden and Germany. A G Unnikrishnan's co-authors include Vasantha Nair, Jayakumar Rajarajeswaran, V. Usha Menon, Harish Kumar, K. R. Sundaram, Carani B. Sanjeevi, Sanjay Singh, Sanjay Kalra, James A. Joseph and Ajay Kumar and has published in prestigious journals such as Annals of the New York Academy of Sciences, The Journal of Pediatrics and Diabetes Research and Clinical Practice.

In The Last Decade

A G Unnikrishnan

25 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A G Unnikrishnan India 9 237 77 61 33 26 27 321
Eduardo Faure Argentina 8 220 0.9× 91 1.2× 44 0.7× 14 0.4× 34 1.3× 16 299
Mohammed Didi United Kingdom 8 214 0.9× 73 0.9× 58 1.0× 42 1.3× 15 0.6× 19 271
Fausta Sestini Italy 9 238 1.0× 139 1.8× 42 0.7× 16 0.5× 62 2.4× 11 324
Soontaree Nakasatien Thailand 10 169 0.7× 56 0.7× 63 1.0× 49 1.5× 32 1.2× 42 260
Sau-Cheung Tiu China 7 172 0.7× 139 1.8× 24 0.4× 55 1.7× 40 1.5× 7 298
Huan Zhou China 9 170 0.7× 47 0.6× 27 0.4× 80 2.4× 47 1.8× 19 298
Patrick C. Hanley United States 4 126 0.5× 36 0.5× 47 0.8× 39 1.2× 11 0.4× 7 200
Danuta Galicka-Latała Poland 8 95 0.4× 90 1.2× 37 0.6× 36 1.1× 35 1.3× 33 297
John Seth United Kingdom 9 307 1.3× 63 0.8× 43 0.7× 66 2.0× 13 0.5× 13 365
Daniel M. Duffy United States 6 147 0.6× 124 1.6× 96 1.6× 32 1.0× 39 1.5× 8 356

Countries citing papers authored by A G Unnikrishnan

Since Specialization
Citations

This map shows the geographic impact of A G Unnikrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A G Unnikrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A G Unnikrishnan more than expected).

Fields of papers citing papers by A G Unnikrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A G Unnikrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A G Unnikrishnan. The network helps show where A G Unnikrishnan may publish in the future.

Co-authorship network of co-authors of A G Unnikrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of A G Unnikrishnan. A scholar is included among the top collaborators of A G Unnikrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A G Unnikrishnan. A G Unnikrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Kamal, Tiny Nair, Manoj Chawla, et al.. (2024). INNOVATOR VS. GENERIC: THE REAL MCCOY VS. THE PRETENDER?.
2.
Saboo, Banshi, et al.. (2022). A prospective multicentre open label study to assess effect of Teneligliptin on glycemic control through parameters of time in range (TIR) Metric using continuous glucose monitoring (TOP-TIR study). Diabetes & Metabolic Syndrome Clinical Research & Reviews. 16(2). 102394–102394. 3 indexed citations
3.
Sethi, Bipin, et al.. (2022). Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus. Diabetes Therapy. 13(8). 1409–1481. 1 indexed citations
5.
Jain, Sunil, Krishna Seshadri, A G Unnikrishnan, et al.. (2020). Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method. Diabetes Therapy. 11(3). 621–632. 8 indexed citations
6.
Das, Ashok Kumar, Sanjay Kalra, Mangesh Tiwaskar, et al.. (2019). Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).. PubMed. 67(12). 65–74. 15 indexed citations
7.
Kalra, Sanjay, Ashok Kumar Das, Sarita Bajaj, et al.. (2018). Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps. Advances in Therapy. 35(10). 1519–1534. 7 indexed citations
8.
Unnikrishnan, A G, Sailesh Lodha, & Sanjeev Sharma. (2017). Consensus on Insulin Dose Modification During Fasting in Type 2 Diabetes.. PubMed. 65(3 Suppl). 7–15. 2 indexed citations
9.
Balhara, Yatan Pal Singh, Sanjay Kalra, Pooja Patnaik Kuppili, et al.. (2017). Indian College of Physicians Position Statement: Addictive Disorders Among Persons with Diabetes Mellitus.. PubMed. 65(12). 11–12. 1 indexed citations
10.
Sahay, Rakesh, et al.. (2014). PO162 BURDEN OF CHRONIC KIDNEY DISEASE AMONG TYPE 2 DIABETICS IN INDIA. Diabetes Research and Clinical Practice. 106. S130–S130. 1 indexed citations
11.
Kumar, Ajay, Surendra Kumar Sharma, Rajesh Rajput, & A G Unnikrishnan. (2013). Initiating therapy or switching to biphasic insulin aspart improves glycaemic control in type 2 diabetes: an Indian experience from the A1chieve study.. PubMed. 61(1 Suppl). 16–20. 6 indexed citations
12.
Kalra, Sanjay, et al.. (2013). Improving adherence to insulin: Hope with degludec. 2(1). 1–2. 3 indexed citations
13.
Unnikrishnan, A G, et al.. (2009). Turner syndrome and its variants. The Indian Journal of Pediatrics. 77(2). 193–195. 10 indexed citations
14.
Menon, V. Usha, K. R. Sundaram, A G Unnikrishnan, et al.. (2009). High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population.. PubMed. 107(2). 72–7. 150 indexed citations
16.
Unnikrishnan, A G, et al.. (2005). Diencephalic Cachexia: A Rare Cause for Failure to Thrive. The Journal of Pediatrics. 147(5). 713–713. 2 indexed citations
17.
Unnikrishnan, A G, Sanjay Singh, & Carani B. Sanjeevi. (2004). Prevalence of GAD65 Antibodies in Lean Subjects with Type 2 Diabetes. Annals of the New York Academy of Sciences. 1037(1). 118–121. 24 indexed citations
18.
Jyotsna, Viveka P., Singh Sk, A G Unnikrishnan, et al.. (2002). Clinical and biochemical profiles of young diabetics in North-Eastern India.. PubMed. 50. 1130–4. 13 indexed citations
19.
Unnikrishnan, A G & Shantha M. W. Rajaratnam. (2001). A young man with seizures, abusive behaviour, and drowsiness. Postgraduate Medical Journal. 77(903). 54–54. 3 indexed citations
20.
Unnikrishnan, A G, et al.. (2001). The 'hook effect' on serum prolactin estimation in a patient with macroprolactinoma.. PubMed. 49(1). 78–80. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026